KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Asset Utilization Ratio: 2013-2025

Historic Asset Utilization Ratio for Sarepta Therapeutics (SRPT) over the last 10 years, with Jun 2025 value amounting to 0.52.

  • Sarepta Therapeutics' Asset Utilization Ratio rose 14.30% to 0.52 in Q2 2025 from the same period last year, while for Jun 2025 it was 0.52, marking a year-over-year increase of 14.30%. This contributed to the annual value of 0.53 for FY2024, which is 35.31% up from last year.
  • As of Q2 2025, Sarepta Therapeutics' Asset Utilization Ratio stood at 0.52, which was up 20.09% from 0.43 recorded in Q1 2025.
  • Sarepta Therapeutics' 5-year Asset Utilization Ratio high stood at 0.52 for Q2 2025, and its period low was 0.20 during Q1 2021.
  • Over the past 3 years, Sarepta Therapeutics' median Asset Utilization Ratio value was 0.43 (recorded in 2025), while the average stood at 0.42.
  • As far as peak fluctuations go, Sarepta Therapeutics' Asset Utilization Ratio skyrocketed by 40.68% in 2021, and later declined by 0.37% in 2025.
  • Quarterly analysis of 5 years shows Sarepta Therapeutics' Asset Utilization Ratio stood at 0.24 in 2021, then rose by 22.90% to 0.30 in 2022, then spiked by 31.38% to 0.39 in 2023, then grew by 28.93% to 0.50 in 2024, then climbed by 14.30% to 0.52 in 2025.
  • Its last three reported values are 0.52 in Q2 2025, 0.43 for Q1 2025, and 0.50 during Q4 2024.